Clinical practice of a novel molecular diagnostic method for detecting Helicobacter pylori and clarithromycin resistance
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 2025
DOI: 10.5387/fms.25-00004 ↗Kurz gefasst
Fachartikel in der Zeitschrift FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2025. Verfasst von Eisuke Kameoka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Japanese Red Cross Society Fukushima Hospital. Hauptthemen laut MEDLINE: Helicobacter pylori, Clarithromycin, Helicobacter Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: The Smart GeneTM system enables the rapid polymerase chain reaction-based detection of Helicobacter pylori (H. pylori) in gastric juice and determines clarithromycin (CAM) resistance. This study evaluated the clinical utility of the Smart GeneTM system for diagnosing and managing H. pylori infection. METHODS: H. pylori diagnosis was obtained using the Smart GeneTM system and the effectiveness of individualized eradication therapy was evaluated. Treatment regimens were chosen based on CAM sensitivity in the Smart GeneTM test. RESULTS: A total of forty-nine patients were assessed. Among them, 28 had H. pylori infection, while 3 had CAM resistance. Seventeen patients underwent H. pylori eradication therapy. Fourteen patients with CAM-sensitive strains underwent eradication therapy with vonoprazan (VPZ), amoxicillin (AMPC), and CAM. Two patients with CAM-resistant strains were treated with VPZ and AMPC, while one received VPZ, AMPC, and metronidazole. The eradication achievement rate was 100%. Of 31 outpatients, 61.5% began H. pylori eradication therapy on the same day as the Smart GeneTM test. CONCLUSION: Smart GeneTM enables rapid diagnosis of H. pylori infection and the detection of CAM resistance, allowing for personalized eradication regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Japanese Red Cross Society Fukushima Hospital.
- Department of Gastroenterology, Fukushima Medical University School of Medicine.
- Department of Endoscopy, Fukushima Medical University Hospital.
Zitieren
APA
Kameoka, E., Hikichi, T., Konno, N., Irie, H., Kanno, Y., Ishizaki, Y., Goto, S., Kuroda, M., Otsuka, M., Yanagita, T., Kato, T., Nakamura, J., Ohira, H., & Kodama, K. (2025). Clinical practice of a novel molecular diagnostic method for detecting Helicobacter pylori and clarithromycin resistance. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. https://doi.org/10.5387/fms.25-00004
Vancouver
Kameoka E, Hikichi T, Konno N, Irie H, Kanno Y, Ishizaki Y, et al. Clinical practice of a novel molecular diagnostic method for detecting Helicobacter pylori and clarithromycin resistance. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 2025. doi:10.5387/fms.25-00004
BibTeX
@article{Kameoka2025,
author = {Kameoka, Eisuke and Hikichi, Takuto and Konno, Naoki and Irie, Hiroki and Kanno, Yukiko and Ishizaki, Yuto and Goto, Sayuri and Kuroda, Masahito and Otsuka, Mitsuru and Yanagita, Takumi and Kato, Tsunetaka and Nakamura, Jun and Ohira, Hiromasa and Kodama, Kenta},
title = {Clinical practice of a novel molecular diagnostic method for detecting Helicobacter pylori and clarithromycin resistance},
journal = {FUKUSHIMA JOURNAL OF MEDICAL SCIENCE},
year = {2025},
doi = {10.5387/fms.25-00004}
}
EUVIMED